CalciMedica
CALC
41 hedge funds and large institutions have $63.7M invested in CalciMedica in 2021 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 4 increasing their positions, 15 reducing their positions, and 27 closing their positions.
11% less capital invested
Capital invested by funds: $71.8M → $63.7M (-$8.01M)
20% less funds holding
Funds holding: 51 → 41 (-10)
37% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 27
50% less call options, than puts
Call options by funds: $1.53M | Put options by funds: $3.05M
73% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Manhattan
New York
|
+$1.37M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.26M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$898K |
| 4 |
SC
Sculptor Capital
New York
|
+$613K |
| 5 |
HF
HRT Financial
New York
|
+$132K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.49M |
| 2 |
BlackRock
New York
|
-$1.35M |
| 3 |
GH
Grosvenor Holdings
Chicago,
Illinois
|
-$1.2M |
| 4 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$1.16M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$1.15M |
CALC Hedge Fund Activity: Q2 2021 in Review
41 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in CalciMedica (CALC) for Q2 2021, worth a combined $63.7M — down 11% from $71.8M a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of CALC and 17 opened new positions — a net loss of 10 holders — while 15 trimmed existing stakes and 4 added.
The largest buyer was First Manhattan, opening a new position worth an estimated $1.37M. The largest seller was Morgan Stanley, cutting an estimated $1.49M.
- 41 institutional investors held CalciMedica (CALC) as of Q2 2021, down from 51 in Q1 2021.
- Funds reported $63.7M of CalciMedica stock for Q2 2021, down 11% quarter-over-quarter.
- 17 funds opened new CalciMedica positions in Q2 2021 and 27 closed out, a net change of -10 holders.
- The largest CalciMedica buyer in Q2 2021 was First Manhattan, an estimated $1.37M added.
- The largest CalciMedica seller in Q2 2021 was Morgan Stanley, an estimated $1.49M sold.
Based on aggregated 13F filings for Q2 2021.